TITLE

Prescribing less expensive medicine

AUTHOR(S)
Barton, Joe
PUB. DATE
April 2006
SOURCE
Fort Worth Business Press;4/24/2006, Vol. 19 Issue 17, Special section p3
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
Focuses on the enrollment of senior citizens in the Part D Medicare drug program under the Medicare Modernization Act in the U.S. Role of drugs in mitigating serious diseases; Number of Texans who are receiving prescription drug coverage under the program; Savings experienced by those who have already signed up for the program.
ACCESSION #
20826762

 

Related Articles

  • D for Doomed? Huang, Wendy; Mozeson, Mark; Pesile, Jason // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p138 

    The article provides insights on problems associated with the implementation of the Medicare Modernization Act (MMA). According to the article, the U.S. government has underestimated the expenses involved in the implementation. Results from the Wall Street Journal/Harris Online survey showed...

  • New model gauges health risks. Elswick, Jill // Employee Benefit News;May2003, Vol. 17 Issue 6, p1 

    Discusses the testing of the Once Care Street, a predictive population health management system developed by Indianapolis, Indiana-based The Haelan Group., by U.S. firm Procter & Gamble with its Medicare retirees. Overview of the system; Details of the pilot study conducted by the firm among...

  • What's new for the old.  // Crain's New York Business;10/24/2005, Vol. 21 Issue 43, p29 

    This article reports that overall health care spending by seniors in the United States is projected to increase by 75% between 1992 and 2010, according to a new study. Nearly 13% of New York's residents are over the age of 65 years, and that number is expected to rapidly multiply as the first...

  • Study finds seniors skip drugs, risk health because they can't afford drugs. Correa, Tracy // Life Extension;Oct2002, Vol. 8 Issue 10, p26 

    Highlights results of a study documenting the effect of the high cost of prescription drugs on senior citizens in the U.S. Ratio of citizens that skip medication because they can't afford it; Difficulty of paying for health plan that covers prescriptions; Amount of money spent on prescription...

  • Targeting Medicare Consumers. Stensrud, John; Sylvestre, Edward; Sivadas, Eugene // Marketing Health Services;Spring97, Vol. 17 Issue 1, p8 

    This article examines how U.S. health care providers are coping with a market environment that is calling on them to increase access, lower their costs, and raise quality all with diminishing resources. The authors contend that identifying customer preferences is the ideal way to remain...

  • Medicare Marketing Scams.  // Advertising Age;4/10/2006, Vol. 77 Issue 15, p30 

    The article focuses on scams and deceptive marketing related to Medicare drug plans in the U.S. Mary Solis,a coordinator for an anti-fraud program in South Texas, found out that a lot of older people have bought drug plans that did not cover many of their prescriptions. Some even paid hundreds...

  • Medicare: How to navigate the maze.  // Consumer Reports;Dec2010, Vol. 75 Issue 12, p12 

    The article presents information on Medicare, focusing on advice for consumers who are eligible for it. It is recommended that people sign up for Medicare prior to turning 65, as this prevents delays in the start of coverage. It is also important not to put off signing up for Medicare Part B...

  • Study predicts sharply higher costs for drugs in next decade.  // Medical Marketing & Media;Sep2000, Vol. 35 Issue 9, p28 

    Focuses on a study by Families USA, which predicts an increase in the use and costs for prescription drugs for the elderly in the United States. Double-digit percentage increase in overall health costs; Increase in the average number of prescriptions per senior.

  • Medicare Card Launch Mediocre. J.W. // Pharmaceutical Executive;Jul2004, Vol. 24 Issue 7, p24 

    Focuses on issues and controversies surrounding the launch of the Medicare drug discount card on June 1, 2004. Claim of patient groups that the drug-company price increases are offsetting real savings from the card program; Counterclaim of the Pharmaceutical Research and Manufacturers of America...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics